Published in Cancer Weekly, May 11th, 2004
CAD technology has the potential to detect findings that might otherwise be overlooked during the review process, thus increasing cancer detection. CAD technology also is especially effective in identifying calcifications, some of which can be cancerous.
"Receiving FDA approval finalizes the commitment of both companies to merge our premier technologies together in a package that we believe will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.